| UniProt ID | G2E3_HUMAN | |
|---|---|---|
| UniProt AC | Q7L622 | |
| Protein Name | G2/M phase-specific E3 ubiquitin-protein ligase | |
| Gene Name | G2E3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 706 | |
| Subcellular Localization | Nucleus, nucleolus . Cytoplasm . Shuttles between the nucleus and the cytoplasm. In the nucleus, delocalizes from the nucleolus to the nucleoplasm in response to DNA damage. | |
| Protein Description | E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Essential in early embryonic development to prevent apoptotic death.. | |
| Protein Sequence | MNESKPGDSQNLACVFCRKHDDCPNKYGEKKTKEKWNLTVHYYCLLMSSGIWQRGKEEEGVYGFLIEDIRKEVNRASKLKCCVCKKNGASIGCVAPRCKRSYHFPCGLQRECIFQFTGNFASFCWDHRPVQIITSNNYRESLPCTICLEFIEPIPSYNILRSPCCKNAWFHRDCLQVQAINAGVFFFRCTICNNSDIFQKEMLRMGIHIPEKDASWELEENAYQELLQHYERCDVRRCRCKEGRDYNAPDSKWEIKRCQCCGSSGTHLACSSLRSWEQNWECLECRGIIYNSGEFQKAKKHVLPNSNNVGITDCLLEESSPKLPRQSPGSQSKDLLRQGSKFRRNVSTLLIELGFQIKKKTKRLYINKANIWNSALDAFRNRNFNPSYAIEVAYVIENDNFGSEHPGSKQEFLSLLMQHLENSSLFEGSLSKNLSLNSQALKENLYYEAGKMLAISLVHGGPSPGFFSKTLFNCLVYGPENTQPILDDVSDFDVAQIIIRINTATTVADLKSIINECYNYLELIGCLRLITTLSDKYMLVKDILGYHVIQRVHTPFESFKQGLKTLGVLEKIQAYPEAFCSILCHKPESLSAKILSELFTVHTLPDVKALGFWNSYLQAVEDGKSTTTMEDILIFATGCSSIPPAGFKPTPSIECLHVDFPVGNKCNNCLAIPITNTYKEFQENMDFTIRNTLRLEKEESSHYIGH | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 19 | Ubiquitination | LACVFCRKHDDCPNK EEEEEEECCCCCCCC | 53.20 | - | |
| 31 | Acetylation | PNKYGEKKTKEKWNL CCCCCCCCCHHHHHE | 61.60 | 19815605 | |
| 42 | Phosphorylation | KWNLTVHYYCLLMSS HHHEEHHHHHHHHHC | 7.49 | - | |
| 86 | Ubiquitination | LKCCVCKKNGASIGC CEEEEECCCCCEEEE | 56.33 | - | |
| 90 | Phosphorylation | VCKKNGASIGCVAPR EECCCCCEEEEECCC | 22.40 | 26270265 | |
| 101 | Phosphorylation | VAPRCKRSYHFPCGL ECCCCCCCCCCCCCC | 14.41 | 24719451 | |
| 166 | Ubiquitination | ILRSPCCKNAWFHRD CCCCCCCCCCCCCCC | 57.31 | - | |
| 200 | Ubiquitination | NNSDIFQKEMLRMGI CCCHHHHHHHHHCCC | 34.05 | - | |
| 252 | Ubiquitination | DYNAPDSKWEIKRCQ CCCCCCCCCEEEECC | 57.11 | - | |
| 290 | Phosphorylation | LECRGIIYNSGEFQK HCCCEEEECCCHHHH | 11.01 | 29496907 | |
| 292 | Phosphorylation | CRGIIYNSGEFQKAK CCEEEECCCHHHHHH | 23.80 | 25159151 | |
| 297 | Ubiquitination | YNSGEFQKAKKHVLP ECCCHHHHHHHHCCC | 68.45 | - | |
| 300 | Ubiquitination | GEFQKAKKHVLPNSN CHHHHHHHHCCCCCC | 43.75 | - | |
| 312 | Phosphorylation | NSNNVGITDCLLEES CCCCCCHHHHHHHCC | 18.09 | 23898821 | |
| 319 | Phosphorylation | TDCLLEESSPKLPRQ HHHHHHCCCCCCCCC | 42.43 | 25159151 | |
| 320 | Phosphorylation | DCLLEESSPKLPRQS HHHHHCCCCCCCCCC | 29.36 | 25159151 | |
| 322 | Ubiquitination | LLEESSPKLPRQSPG HHHCCCCCCCCCCCC | 73.41 | - | |
| 327 | Phosphorylation | SPKLPRQSPGSQSKD CCCCCCCCCCHHHHH | 32.29 | 25159151 | |
| 330 | Phosphorylation | LPRQSPGSQSKDLLR CCCCCCCHHHHHHHH | 34.36 | 28102081 | |
| 332 | Phosphorylation | RQSPGSQSKDLLRQG CCCCCHHHHHHHHHH | 29.81 | 28102081 | |
| 333 | Ubiquitination | QSPGSQSKDLLRQGS CCCCHHHHHHHHHHH | 44.77 | - | |
| 347 | Phosphorylation | SKFRRNVSTLLIELG HHHHHHHHHHHHHHC | 19.52 | 22210691 | |
| 348 | Phosphorylation | KFRRNVSTLLIELGF HHHHHHHHHHHHHCC | 22.69 | 22210691 | |
| 435 | Phosphorylation | GSLSKNLSLNSQALK CCCCCCCCCCCHHHH | 34.59 | 26270265 | |
| 438 | Phosphorylation | SKNLSLNSQALKENL CCCCCCCCHHHHHCH | 23.32 | 26270265 | |
| 442 | Ubiquitination | SLNSQALKENLYYEA CCCCHHHHHCHHHHH | 47.80 | 21890473 | |
| 571 | Ubiquitination | KTLGVLEKIQAYPEA HHHHHHHHHHHCCHH | 35.64 | - | |
| 586 | Ubiquitination | FCSILCHKPESLSAK HHHHHCCCCHHHHHH | 49.86 | - | |
| 688 | Phosphorylation | FQENMDFTIRNTLRL HHHHCCCCHHHCEEE | 18.11 | 24719451 | |
| 697 | Ubiquitination | RNTLRLEKEESSHYI HHCEEECCCCCCCCC | 71.96 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of G2E3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of G2E3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of G2E3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CYTSA_HUMAN | SPECC1L | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...